← Evidence map

ArticlePharmacological reports : PR2025

Eribulin exerts multitarget antineoplastic activity in glioma cells.

Guilherme Augusto Sousa Alcântara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40056292